二尖瓣手术教科书结局:荷兰心脏注册研究结果
该研究基于荷兰心脏注册数据,纳入2013至2021年3026例首次择期二尖瓣手术患者,评估手术特异性教科书结局(TO)并分析非TO相关因素。结果显示87.1%患者达到TO,年龄、左室射血分数降低、肺动脉高压、近期心梗、二尖瓣置换、胸骨入路及心律手术与非TO独立相关。
要点
- 87.1%患者达到二尖瓣手术特异性教科书结局。
- 二尖瓣置换较修复与非TO风险独立相关(OR=1.89)。
- 近期心梗与非TO风险显著相关(OR=4.71)。
核心结论
- 教科书结局是评估二尖瓣手术性能的临床相关指标,可作为基准。
研究设计与样本
- 回顾性队列研究,纳入荷兰心脏注册2013-2021年3026例首次择期二尖瓣手术患者。
主要发现
- 87.1%(n=2637)患者达到二尖瓣手术特异性教科书结局。
- 非TO独立相关因素包括年龄(OR=1.03,95%CI 1.01-1.03,P=.01)、左室射血分数<50%(OR=1.33,95%CI 1.02-1.72,P=.03)、肺动脉高压(OR=1.30,95%CI 1.00-1.68,P=.05)、近期心梗(OR=4.71,95%CI 1.79-12.38,P=.01)、二尖瓣置换(OR=1.89,95%CI 1.48-2.41,P<.01)、胸骨入路(OR=1.30,95%CI 1.02-1.66)及心律手术(OR=1.33,95%CI 1.03-1.71,P=.03)。
关键数值与推荐
- 二尖瓣手术特异性TO定义为无呼吸功能不全、延长插管、ICU再入院、术后卒中、肾衰竭、大血管并发症、纵隔炎、因出血再干预,且1年存活、1年内无再干预。
临床怎么用
- 可将TO作为二尖瓣手术质量评估与基准比较的指标,并关注非TO相关因素以优化患者选择与围术期管理。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Historically, surgical results have been evaluated based on morbidity and mortality end-points. Still, patient expectations are centred around the absence of any important complications. Recently, textbook outcome (TO) has been introduced to represent such a result. The main objective of this study is to evaluate TO in mitral valve (MV) surgery and identify factors associated with (non-)TO. METHODS: All patients undergoing primary elective MV surgery (± tricuspid valve [TV] surgery, atrial septum defect closure, rhythm surgery) in the Netherlands between 2013 and 2021 were included from the Netherlands Heart Registration. The primary end-point was MV surgery-specific TO, which was defined as absence of respiratory insufficiency, prolonged intubation, readmission to intensive care unit (ICU), postoperative stroke, renal failure, major vascular complications, mediastinitis, and reintervention for bleeding, while also being alive at 1 year, without a reintervention at 1 year. RESULTS: A total of 3026 patients were included. Mean age was 64.7 ± 11.6 years. TO was achieved in 87.1% of patients (n = 2637). Factors independently associated with non-TO were: age (OR = 1.03, 95% CI, 1.01-1.03 P = .01), reduced left ventricular ejection fraction (<50%) (OR = 1.33, 95% CI, 1.02-1.72 P = .03), pulmonary hypertension (OR = 1.30, 95% CI, 1.00-1.68 P = .05), recent myocardial infarction (OR = 4.71, 95% CI, 1.79-12.38 P = .01), mitral valve replacement (OR = 1.89, 95% CI, 1.48-2.41 P < .01), sternotomy approach (OR = 1.30, 95% CI, 1.02-1.66), and rhythm surgery (OR = 1.33, 95% CI, 1.03-1.71, P = .03). CONCLUSIONS: TO is a clinically relevant measure which can serve as a benchmark to evaluate surgical performance. Future studies may focus on the validation of these results and its application to other procedures.
引用
- Ko K, Heuts S, Tjon Joek Tjien A, et al. Textbook Outcome in Mitral Valve Surgery-Results from the Netherlands Heart Registration. Eur J Cardiothorac Surg. 2025. PMID: 41289055. doi:10.1093/ejcts/ezaf422
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。